Sallie Rosen Kaplan Fellowship for Women in Basic, Clinical, Epidemiological or Prevention Science
The Sallie Rosen Kaplan Fellowship for Women Scientists in Cancer Research is made possible by a generous
bequest to the Foundation for NIH (FNIH). This is a competitive program for postdoctoral fellows applying to
train in any of the National Cancer Institute's intramural research settings, including basic, clinical,
epidemiological, and prevention science.
The postdoctoral fellowship experience at the NCI can serve as a first postdoctoral training assignment,
or offer more experienced postdoctoral scientists an opportunity to further their training in more advanced
methods, to acquire new research capabilities, to make changes in the direction of their research, or to
receive training in fundamental sciences and clinical disciplines for the purpose of enhancing the transfer
of biotechnology to cancer clinical programs.
Program duration is normally 2 to 5 years. Fellows will be supported by a Cancer Research Training Award
(CRTA), with an augmented stipend in the first year provided by the FNIH. The CRTA Fellowship stipend range
is $46,200 to $78,000 commensurate with level of experience. Standard self and family health insurance is
provided and high option coverage is available.
Candidates for the Sallie Rosen Kaplan Fellowship must be female, must possess a doctoral degree, and must
have less than 5 years postdoctoral research experience. U.S. citizenship or U.S. permanent residency
(green card) is required. Finalists for the Kaplan fellowship will be notified by March 2009 and winners
announced by May 2009. To be eligible for the Sallie Rosen Kaplan Fellowship award, the starting date of
any NCI fellowship must be no earlier than December 15, 2008. Applicants are required to apply online at
http://www.training.nih.gov/apps/publicForms/postdoctoral/forms/adIndex.aspx by December 12, 2008.
Questions concerning the Sallie Rosen Kaplan Fellowship may be addressed to Ms. Sandy Koeneman at
koenemas@mail.nih.gov or 301-496-0807.
—posted 7/2/2008
 |
Reminder for "Avon–NCI Progress for Patients" Applications
This is a reminder that applications in response to “Avon–NCI Progress for Patients” (PFP)
Awards Program: A Special Public;ndash;Private Initiative in Early Phase Clinical Interventions and Biomarkers
in Breast Cancer will be due November 15, 2007. You are advised to view the
Program Announcement for specific instructions.
As with the April, 2007 solicitation, the announcement includes additional requirements
which applicants should take special note of: 1) Each competitive supplement application should
be submitted by the Principal Investigator of the parent P30 grant; 2) Avon–NCI PFP applications
will not be accepted when the proposed funding period extends beyond the end date of the parent
P30 5–year project period; 3) If investigators from other Cancer Centers/SPOREs are included
in the application as subcontractors, the funding period of these subcontractors should not
exceed their respective parent P50/P30 project period; and 4) Previously unfunded, revised
projects must be resubmitted as new rather than amended applications.
We encourage you to participate in this program and help us make the “Avon–NCI Progress
for Patients” a turning point in the fight against breast cancer. Letters of intent,
while not required, are helpful in planning the review and should be forwarded as soon as
possible if you plan to submit an application.
Please contact the Cancer Centers Branch staff identified under agency contacts in the
NIH guide announcement for any questions you may have regarding eligibility or other requirements.
—posted 10/16/2007
Supplements for caBIG™
We are pleased to announce the availability of supplemental funding for deployment
of cancer Biomedical Informatics Grid (caBIG™) compatibility products in the
NCI–designated Cancer Centers. During the three year pilot phase, caBIG™
focused on identifying and adopting interoperability standards for biomedical
information systems that support cancer research. Since the inception of the
caBIG™ program, the NCI Cancer Centers have taken the primary role in
development, testing, and adoption of caBIG™ technologies. Now that the
pilot phase is complete, the NCI Center for Biomedical Informatics and
Information Technology (CBIIT) and the NCI Cancer Centers Branch (CCB)
are pursuing an enterprise–wide expansion strategy to support cancer centers
in their efforts to assess their internal readiness and capabilities as
they prepare for caBIG™ deployment in their research enterprise.
The supplement will support .5 FTE (with fringe benefits) of a senior staff
person to undertake the tasks necessary to assess and prepare the Cancer
Center to implement the appropriate caBIG™ resource bundles that have
been developed. The Center must agree to match NCI funding with an equivalent
level of support to ensure that 1.0 FTE of the same staff person is fully
dedicated to the process outlined in the attached guidelines.
Additional details relevant to this supplemental funding are included at the
following links.
They include: 1)
background information on caBIG™ and the three resource
bundles that have been developed during the pilot phase; 2) a short set of
guidelines providing information on the expected scope of work, implementation
success criteria, application instructions, and contact information for
questions; and 3) a
response template to complete and return with the other
application documents listed in the guidelines.
Due to the need to fund these awards prior to the end of the 2007 fiscal year,
we require your response to this solicitation no later than August 31, 2007.
The template referenced above is provided to facilitate your response within
this short time frame. The applications will be administratively reviewed by CBIIT
and CCB staff for responsiveness to the instructions in the guidelines. All
NCI–designated Cancer Centers are eligible to apply for funding and all
applications that are deemed responsive will be funded by September 30, 2007.
Please contact relevant contact persons indicated in the guidelines if you
have questions. —posted 4/2/2007
Clarification on Avon Progress for Patients Applications
The following information is intended to clarify guidelines for the 2007 Avon –
NCI Partners for Progress (PFP) Awards Program. The clarification relates to project
periods proposed in PFP application(s). It applies to the submitting Center as well
as to all other Centers/SPOREs collaborating on the same project.
- No PFP supplement project may be proposed for more than 2 years’ duration.
The funding period of the supplement award may not extend beyond the end date
of the associated 5–year parent grant award project period.
- Centers/SPOREs with 2 or more years remaining in the “parent”
grant project period (at the time of the proposed competitive supplement funding
start date) may submit a PFP supplement application for a project of either 1
or 2 full years in duration, but not for fractions thereof. If fewer than 2
years (but at least 1 year) remain in the “parent” project period,
the applicant may only submit a PFP supplement application for 1 year of support.
- The proposed PFP supplement project Principal Investigator (PI) must be the
PI of the “parent” grant.
- Applicants are encouraged (but not required) to submit a
Letter of Intent (LOI) prior to submitting applications for PFP supplements.
Questions regarding PFP supplements should be directed to the Program Director
referenced in the original announcement.—posted 4/2/2007
|
|
Avon – NCI 2007 Progress for Patients Supplemental Awards
We are pleased to announce the 2007 "Avon – NCI Progress for Patients
(PFP) Awards Program: A Special Public–Private Initiative in Early Phase
Clinical Interventions and Biomarkers in Breast Cancer supported by a
partnership between the Avon Foundation and the National Cancer Institute
(NCI). Applications in response to the fifth solicitation will be due
April 27, 2007, and November 15, 2007. You are advised to view Program Announcement
at
http://grants.nih.gov/grants/guide/pa-files/PAR-07-244.html for specific instructions.
The announcement has been modified from the previous guidelines to include
additional new requirements, which applicants should take special note of:
1) Each competitive supplement application should be submitted by the Principal
Investigator of the parent P30 grant; 2) Avon–NCI PFP applications will not
be accepted when the proposed funding period extends beyond the end date of
the parent P30 5–year project period; 3) If investigators from other Cancer
Centers/SPOREs are included in the application as subcontractors, the
funding period of these subcontractors should not exceed their respective
parent P50/P30 project period; and 4) Previously unfunded, revised projects
must be resubmitted as new rather than amended applications.
We encourage you to participate in this program and help us make the Avon–NCI
Progress for Patients a turning point in the fight against breast cancer.
Please contact the Cancer Centers Branch staff identified under agency contacts
in the NIH guide announcement for any questions you may have. Guidelines for
applications in response to the Avon – NCI 2006 Progress for Patients Awards
are now available, with letters of intent and applications due February 1 and
March 1, respectively. —posted 3/6/2007
|
|
Sallie Rosen Kaplan Fellowship
The Sallie Rosen Kaplan Fellowship is an opportunity for women postdoctoral
scientists in cancer research, made possible by a generous bequest to the
Foundation for NIH (FNIH). Candidates for the Kaplan Fellowship must possess
a doctoral degree earned within the last five years. Current doctorate students
are also eligible to apply considering that all degree requirements will be
completed prior to the beginning of the fellowship. U.S. citizenship or U.S.
permanent residency (green card) is required. The postdoctoral fellowship
experience at the NCI can serve as a first postdoctoral training assignment,
or offer more experienced postdoctoral scientists an opportunity to further
their training in more advanced methods, to acquire new research capabilities,
to make changes in the direction of their research, or to receive training
in fundamental sciences and clinical disciplines for the purpose of enhancing
the transfer of biotechnology to cancer clinical programs. Program duration
is normally 2 to 5 years. Current NCI postdoctoral fellows are not eligible
to apply.
NCI facilities are located in Bethesda, Rockville, Gaithersburg and Frederick,
Maryland, and are the best funded and equipped research laboratories in the
United States. As a member institute of the National Institutes of Health, the
NCI offers an environment for postdoctoral fellows to interact with scientists
from a wide range of medical/life science disciplines, attend lectures given by
internationally renowned scientists, and participate in meetings sponsored by
national scientific associations and societies. Fellows will be supported by a
Cancer Research Training Award (CRTA), with an augmented stipend in the first
year provided by the FNIH. The CRTA Fellowship stipend range is $39,800 to $73,500
commensurate with level of experience. The amount of first–year stipend augmentation
will depend upon the available bequest income and number of Kaplan Fellows selected.
Standard self and family health insurance is provided and high option coverage
is available. The fellowship starting date will be no earlier than May 1, 2007.
NCI is proud to support the Kaplan family in its efforts to promote the careers
of women in biomedical research. You can help by sharing this information with
fellows you know who would benefit from this opportunity. While we are certainly
making efforts to publicize this information in a variety of formats to our target
audience, we know that you are in the best position to recommend fellows to the
program. Completed applications are due Friday, December 15th.
Applicants are required to apply online. For eligibility information and application
instructions for this special opportunity, please go to our training and employment
website:
http://generalemployment.nci.nih.gov. Click on Enter StarCatcher, then Sallie
Rosen Kaplan Postdoctoral Fellowship, and then click on SRK Opportunity.
If you would like printed brochures or flyers or if you have any questions about
the program or the application process, please send an email to
ncifellows@mail.nih.gov
or contact us by phone, 301.451.8826. —posted 10/17/2006
|
